© Reuters. FILE PHOTO: Unilever logo is displayed in this illustration taken on January 17, 2022. REUTERS/Dado Ruvic/Illustration
(Reuters) – Unilever (NYSE:)’s shares rose 5% on Monday following reports activist investor Nelson Peltz has built a stake in the consumer goods maker, as its strategy comes under scrutiny after effectively abandoning the pursuit of GlaxoSmithKline (NYSE:)’s consumer healthcare business.
Peltz’s activist hedge fund, Trian Partners, has built an unspecified stake in Unilever, a person familiar with the matter told Reuters on Sunday. New York-based Trian is known for proposing operational fixes at its portfolio companies.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Russia bans Biden but not Trump, on list of Americans travel-barred
President Donald Trump and Russian President Vladimir Putin arrive for a joint news conference after their meeting in Helsinki, July…
Nvidia’s data-center sales likely to eclipse gaming — that might not be a good thing
Nvidia Corp.’s data-center sales are expected to edge out its gaming sales in fiscal first-quarter results, as demand from server…